April 2016: Farhad Hafezi to become Honorary member of Hungary’s SHIOL
ELZA physician Prof. Farhad Hafezi gives a keynote lecture on CXL technology and becomes a Honorary Member of the society.
Prof. Farhad Hafezi
April 8, 2016
ELZA physician Prof. Farhad Hafezi gives a keynote lecture on CXL technology and becomes a Honorary Member of the society.
This clinical study by Alireza Peyman, with the participation of the ELZA members Farhad Hafezi and Sabine Kling, investigated whether the use of pulsed UV light would increase the biomechanical cross-linking effect, as suggested by others previously.
The ELZA member Prof. Farhad Hafezi gives the International Keynote lecture on “PACK-Cross-Linking for infectious keratitis” at the Annual meeting of the Bowman Club, the association of UK corneal specialists
Article on CXL for keratoconus in the latest edition of the Dept. of Ophthalmology’s newsletter “UpClose”, where Professor Hafezi serves as Clinical Professor
Article about ELZA’s large multicenter “Swiss PACK-CXL” trial in 15 countries for the use of cross-linking in corneal infection
Cover story about the Light for Sight foundation and its efforts to bring CXL therapy to a young patient
Prof. Hafezi from the ELZA Institute is invited speaker, explaining the current restrictions in epi-on and accelerated CXL treatment protocols
We are proud and very excited to announce that the Ocular Cell Biology and Keratoconus Research group of Prof. Farhad Hafezi moved from the University of Geneva to the CABMM (Center for Applied Biotechnology and Molecular Medicine) of the University of Zurich per January 1, 2016.
Prof. Hafezi speaks about CXL technology in 2016, upon invitation of Prof. Lim Li.
Editorial on the OSN Roundtable discussion, written by Farhad and Nikki Hafezi from ELZA in Switzerland.
